Zafgen Inc (ZFGN) Reports Positive Phase III Results For Obesity Drug Beloranib
Shares of Zafgen Inc (NASDAQ:ZFGN) are up $2.78 or 49.04% in pre-market trading this morning after the company reported positive results for their phase III…
Zafgen Inc – (NASDAQ:ZFGN)
Zafgen Inc (NASDAQ:ZFGN) Shares Down Big Again in Pre-Market After Patient Death
Zafgen Inc (NASDAQ:ZFGN) shares which tumbled more than 60% yesterday after the company announced that a second patient had died during clinical trials for their…
Zafgen’s (NASDAQ:ZFGN) Obesity Drug Claims Second Life, Shares Plummet
Zafgen Inc (NASDAQ:ZFGN) shares are down big in pre market trading this morning after reports indicate that a second patient who had been treated with…
